Logo image of SHCR

SHARECARE INC (SHCR) Stock Fundamental Analysis

NASDAQ:SHCR - Nasdaq - US81948W1045 - Common Stock - Currency: USD

1.43  -0.01 (-0.35%)

After market: 1.43 0 (0%)

Fundamental Rating

3

SHCR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. The financial health of SHCR is average, but there are quite some concerns on its profitability. SHCR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SHCR has reported negative net income.
In the past year SHCR has reported a negative cash flow from operations.
SHCR had negative earnings in each of the past 5 years.
In multiple years SHCR reported negative operating cash flow during the last 5 years.
SHCR Yearly Net Income VS EBIT VS OCF VS FCFSHCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

SHCR has a Return On Assets (-24.25%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -31.01%, SHCR is in line with its industry, outperforming 59.46% of the companies in the same industry.
Industry RankSector Rank
ROA -24.25%
ROE -31.01%
ROIC N/A
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHCR Yearly ROA, ROE, ROICSHCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

SHCR's Gross Margin of 44.04% is on the low side compared to the rest of the industry. SHCR is outperformed by 67.57% of its industry peers.
SHCR's Gross Margin has declined in the last couple of years.
SHCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
SHCR Yearly Profit, Operating, Gross MarginsSHCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

SHCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SHCR has less shares outstanding than it did 1 year ago.
The debt/assets ratio for SHCR is higher compared to a year ago.
SHCR Yearly Shares OutstandingSHCR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M
SHCR Yearly Total Debt VS Total AssetsSHCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

SHCR has an Altman-Z score of 0.73. This is a bad value and indicates that SHCR is not financially healthy and even has some risk of bankruptcy.
SHCR's Altman-Z score of 0.73 is in line compared to the rest of the industry. SHCR outperforms 48.65% of its industry peers.
SHCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.73
ROIC/WACCN/A
WACC9.12%
SHCR Yearly LT Debt VS Equity VS FCFSHCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

SHCR has a Current Ratio of 2.02. This indicates that SHCR is financially healthy and has no problem in meeting its short term obligations.
SHCR has a Current ratio (2.02) which is comparable to the rest of the industry.
A Quick Ratio of 2.02 indicates that SHCR has no problem at all paying its short term obligations.
SHCR has a Quick ratio of 2.02. This is comparable to the rest of the industry: SHCR outperforms 59.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
SHCR Yearly Current Assets VS Current LiabilitesSHCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SHCR have decreased strongly by -11.43% in the last year.
SHCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.11%.
Measured over the past years, SHCR shows a quite strong growth in Revenue. The Revenue has been growing by 10.63% on average per year.
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%

3.2 Future

The Earnings Per Share is expected to grow by 11.33% on average over the next years. This is quite good.
Based on estimates for the next years, SHCR will show a small growth in Revenue. The Revenue will grow by 0.95% on average per year.
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHCR Yearly Revenue VS EstimatesSHCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
SHCR Yearly EPS VS EstimatesSHCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SHCR. In the last year negative earnings were reported.
Also next year SHCR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHCR Price Earnings VS Forward Price EarningsSHCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHCR Per share dataSHCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.49%
EPS Next 3Y11.33%

More info and screens

0

5. Dividend

5.1 Amount

SHCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHARECARE INC

NASDAQ:SHCR (10/21/2024, 8:00:02 PM)

After market: 1.43 0 (0%)

1.43

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-09 2024-08-09/bmo
Earnings (Next)11-07 2024-11-07/bmo
Inst Owners38.79%
Inst Owner Change-22.77%
Ins Owners0.1%
Ins Owner Change0%
Market Cap531.79M
Analysts48.89
Price Target1.46 (2.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.56%
Min EPS beat(2)-68.07%
Max EPS beat(2)-47.05%
EPS beat(4)1
Avg EPS beat(4)-39.36%
Min EPS beat(4)-68.07%
Max EPS beat(4)8.5%
EPS beat(8)1
Avg EPS beat(8)-38.89%
EPS beat(12)2
Avg EPS beat(12)-55.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.26%
Min Revenue beat(2)-12.09%
Max Revenue beat(2)-2.43%
Revenue beat(4)0
Avg Revenue beat(4)-6.75%
Min Revenue beat(4)-12.09%
Max Revenue beat(4)-2.22%
Revenue beat(8)3
Avg Revenue beat(8)-2.77%
Revenue beat(12)5
Avg Revenue beat(12)-2.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.32
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 4.32
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS1.09
BVpS1.18
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.25%
ROE -31.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.04%
FCFM N/A
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.08%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z 0.73
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)6.08%
Cap/Depr(5y)6.54%
Cap/Sales(3y)0.6%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A
EBIT growth 1Y-15.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.69%
EBIT Next 3Y30.06%
EBIT Next 5YN/A
FCF growth 1Y82.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.64%
OCF growth 3YN/A
OCF growth 5YN/A